Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1843 TiviciclovirSummary: An antiviral guanosine analog and a hepatitis B virus inhibitor. -
BA1844 DVR-01Summary: DVR-01 is an inhibitor. -
BA1845 RO6889678Summary: RO6889678 is a potent inhibitor of the coat structure with a complex absorption, distribution, metabolism and excretion (ADME) profile. -
BA1846 ChamaechromoneSummary: Chamaechromone is a biflavonoid constituent isolated from the roots of the thyme family. -
BA1848 IsothiafludineSummary: Isothiafludine is a non-nucleoside anticompound with oral activity. -
BA1849 HBV-IN-37Summary: HBV-IN-37 is an inhibitor. -
BA1850 LagociclovirSummary: Lagociclovir (FLG) is a nucleoside analog. -
BA1851 PibrentasvirSummary: Pibrentasvir is a novel pan-genotypic hepatitis C virus inhibitor. -
BA1853 BLT-1Summary: BLT-1 is a copper thiosemicarbazone chelator and selective scavenger receptor type B1 inhibitor. -
BA1854 DaclatasvirSummary: Daclatasvir (BMS-790052) is a potent orally active protein inhibitor with multiple replicon genotypes ranging from 9-146 pM.

